Pharvaris N.V. (PHVS) — 6-K Filings

6-K Filings (25)

• Pharvaris N.V. Files 6-K with Financial Results — Apr 2, 2026 Risk: low
  Pharvaris N.V. filed a 6-K report on April 2, 2026, for the period ending March 31, 2026. The filing includes financial results and an exhibit (EX-99.1), with a
• Pharvaris N.V. Files December 2025 6-K Report — Dec 3, 2025 Risk: low
  Pharvaris N.V. filed a Form 6-K on December 3, 2025, reporting for the month of December 2025. The company, previously known as Pharvaris, B.V., is a foreign pr
• Pharvaris N.V. Files Routine 6-K Report — Nov 12, 2025 Risk: low
  Pharvaris N.V. filed a Form 6-K on November 12, 2025, reporting for the month of November 2025. The company, previously known as Pharvaris, B.V., is a foreign p
• Pharvaris N.V. Files Routine 6-K Report — Sep 8, 2025 Risk: low
  Pharvaris N.V. filed a Form 6-K on September 8, 2025, reporting for the month of September 2025. The company, previously known as Pharvaris, B.V., is a foreign
• Pharvaris N.V. Files 6-K for Q2 2025 — Aug 12, 2025 Risk: low
  Pharvaris N.V. filed a 6-K report on August 12, 2025, for the period ending June 30, 2025. The filing includes financial data such as gross carrying amounts and
• Pharvaris N.V. Files 6-K, Reports Under Form 20-F — Jul 24, 2025 Risk: low
  Pharvaris N.V. filed a Form 6-K on July 24, 2025, reporting as a foreign private issuer. The filing indicates that the company will file its annual reports unde
• Pharvaris N.V. Files Routine 6-K Report — Jul 10, 2025 Risk: low
  Pharvaris N.V. filed a Form 6-K on July 10, 2025, reporting for the month of July 2025. The company, previously known as Pharvaris, B.V., is incorporated in the
• Pharvaris N.V. Files June 2025 6-K Report — Jun 27, 2025 Risk: low
  Pharvaris N.V. filed a Form 6-K on June 27, 2025, to report on its activities for the month of June 2025. The filing indicates that the company is a foreign pri
• Pharvaris N.V. Files June 2025 6-K Report — Jun 10, 2025 Risk: low
  Pharvaris N.V. filed a Form 6-K on June 10, 2025, to report information for the month of June 2025. The filing indicates that Pharvaris N.V. is a foreign privat
• Pharvaris N.V. Files May 2025 6-K Report — May 13, 2025 Risk: low
  Pharvaris N.V. filed a Form 6-K on May 13, 2025, reporting for the month of May 2025. The company, incorporated in the Netherlands, is a pharmaceutical preparat
• Pharvaris N.V. Files January 2025 6-K Report — Jan 13, 2025 Risk: low
  Pharvaris N.V. filed a Form 6-K on January 13, 2025, reporting for the month of January 2025. The company, incorporated in P7 and headquartered in Leiden, The N
• Pharvaris N.V. Files 6-K Report — Nov 13, 2024 Risk: low
  Pharvaris N.V. filed a Form 6-K on November 13, 2024, to report information for the month of November 2024. The company, previously known as Pharvaris, B.V., is
• Pharvaris N.V. Files September 2024 6-K Report — Sep 25, 2024 Risk: low
  Pharvaris N.V. filed a Form 6-K on September 25, 2024, reporting for the month of September 2024. The company, previously known as Pharvaris, B.V., is incorpora
• Pharvaris N.V. Files Routine 6-K Report — Sep 23, 2024 Risk: low
  Pharvaris N.V. filed a Form 6-K on September 23, 2024, for the month of September 2024. The company, a foreign private issuer, is based in Leiden, The Netherlan
• Pharvaris N.V. Files September 2024 6-K Report — Sep 5, 2024 Risk: low
  Pharvaris N.V. filed a Form 6-K on September 5, 2024, reporting for the month of September 2024. The company, previously known as Pharvaris, B.V., is incorporat
• Pharvaris N.V. Files 6-K with Q2 2024 Financial Updates — Aug 14, 2024 Risk: low
  Pharvaris N.V. filed a 6-K report on August 14, 2024, detailing financial information as of June 30, 2024. The filing includes data related to various financial
• Pharvaris N.V. Files June 2024 6-K Report — Jun 28, 2024 Risk: low
  Pharvaris N.V. filed a Form 6-K on June 28, 2024, to report on its activities for the month of June 2024. The filing indicates that the company is a foreign pri
• Pharvaris N.V. Announces 2024 Annual General Meeting — Jun 11, 2024 Risk: low
  Pharvaris N.V. filed a Form 6-K on June 11, 2024, announcing its Annual General Meeting (AGM) of Shareholders. The meeting is scheduled for July 10, 2024, and w
• Pharvaris N.V. Files June 2024 6-K Report — Jun 4, 2024 Risk: low
  Pharvaris N.V. filed a Form 6-K on June 4, 2024, to report information for the month of June 2024. The company is a foreign private issuer and files annual repo
• Pharvaris N.V. Files 6-K Update — May 8, 2024 Risk: low
  Pharvaris N.V. filed a Form 6-K on May 8, 2024, reporting its status as a foreign private issuer. The company, incorporated in the Netherlands, is providing an
• Pharvaris N.V. Files March 2024 6-K Report — Mar 6, 2024 Risk: low
  Pharvaris N.V. filed a Form 6-K on March 6, 2024, to report its activities for the month of March 2024. The company, a pharmaceutical preparations firm based in
• Pharvaris N.V. Files 6-K, Confirms Foreign Private Issuer Status — Feb 16, 2024 Risk: low
  Pharvaris N.V. (NASDAQ: PHVS) filed a 6-K on February 16, 2024, indicating it is a foreign private issuer submitting reports under Form 20-F. The filing updates
• Pharvaris N.V. Enters Registration Rights Agreement — Feb 7, 2024
  Pharvaris N.V. filed a 6-K on February 7, 2024, announcing it entered into a registration rights agreement on February 5, 2024. This agreement allows certain sh
• Pharvaris N.V. Files 6-K, References Jan 22 Press Release — Jan 22, 2024
  On January 22, 2024, Pharvaris N.V. filed a 6-K report with the SEC, indicating they issued a press release on the same day. This filing is a routine update for
• Pharvaris N.V. Files 6-K for Jan 5 Press Release — Jan 8, 2024
  Pharvaris N.V. filed a 6-K on January 8, 2024, to announce a press release issued on January 5, 2024. This filing indicates that the company is providing update

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX